Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 143,251 | 159,087 | 149,042 | 122,971 | 136,708 |
| Marketable Securities | 117,055 | 101,860 | 123,765 | 90,128 | 67,107 |
| Receivables | 21,235 | 26,841 | 24,699 | 39,136 | 21,469 |
| Income taxes - deferred | N/A | N/A | 710 | 409 | N/A |
| Other current assets | 5,528 | 6,643 | 7,587 | 5,429 | 7,721 |
| TOTAL | $287,069 | $294,431 | $305,803 | $258,073 | $233,005 |
| Non-Current Assets | |||||
| PPE Net | 45,895 | 48,956 | 50,370 | 52,051 | 54,681 |
| Investments And Advances | 7,521 | 7,651 | 0 | 0 | 7,853 |
| Intangibles | 1,116 | 691 | 653 | 677 | 671 |
| Other Non-Current Assets | 41,944 | 44,148 | 50,321 | 43,657 | 38,060 |
| TOTAL | $96,476 | $101,446 | $101,344 | $96,385 | $101,265 |
| Total Assets | $383,544 | $395,876 | $407,147 | $354,459 | $334,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,134 | 5,350 | 5,119 | 5,174 | 5,289 |
| Accounts payable and accrued liabilities | 18,664 | 18,511 | 18,213 | 16,051 | 19,069 |
| Other current liabilities | 10,925 | 11,275 | 10,068 | 8,125 | 11,959 |
| TOTAL | $166,269 | $165,650 | $159,633 | $158,447 | $155,144 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,882 | 61,575 | 58,348 | 62,618 | 49,125 |
| Deferred Revenues | 112,161 | 122,006 | 117,754 | 120,556 | 110,325 |
| Other Non-Current Liabilities | 35,360 | 39,110 | 40,556 | 42,828 | 45,148 |
| TOTAL | $86,242 | $100,803 | $98,904 | $105,446 | $94,431 |
| Total Liabilities | $252,511 | $266,452 | $258,537 | $263,893 | $249,575 |
| Shareholders' Equity | |||||
| Common Shares | 5,889 | 5,906 | 5,897 | 4,376 | 4,365 |
| Retained earnings | -329,607 | -448,481 | -425,356 | -400,165 | -405,766 |
| Other shareholders' equity | -39,537 | -35,154 | -38,077 | -37,241 | -36,689 |
| TOTAL | $131,033 | $129,424 | $148,610 | $90,566 | $84,695 |
| Total Liabilities And Equity | $383,544 | $395,876 | $407,147 | $354,459 | $334,270 |